Jazz Pharmaceuticals Acquires SpringWorks Therapeutics’ FAAH Inhibitor Program
Ryan Allway October 27th, 2020 News, Top News Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) (“SpringWorks”) today announced that Jazz Pharmaceuticals Ireland Limited (“Jazz”) and SpringWorks […]
